SGMT

NASDAQ · Biotechnology

Sagimet Biosciences Inc-A

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$9.34

-0.60 (-6.04%)

As of Sep 29, 2:41 PM ET ·

SGMT News1 articles

Sagimet Biosciences Soars After $175M Stock Sale to Fund Acne Drug Trial

Sagimet Biosciences shares surged 38% after announcing a $175 million stock offering to fund a Phase 3 acne trial for denifanstat, with proceeds expected to support dermatology programs through 2028.